FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

American Health Packaging Aspirin and Extended-release Dipyridamole Recall

Aspirin and Extended-release Dipyridamole Capsules, 25 mg/200 mg, 20 capsules per carto…

American Health Packaging · Columbus, OH

Risk level
Class II
Reported by FDA
Aug 21, 2019
Recall ID
D-1820-2019
Check your lot numberHow we source this data

Summary

American Health Packaging recalled Aspirin and Extended-release Dipyridamole starting Mar 1, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1820-2019 on Aug 21, 2019. Reason: Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples.

Product description

Aspirin and Extended-release Dipyridamole Capsules, 25 mg/200 mg, 20 capsules per carton (5 blister cards x 4 unit doses), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-305-32; NDC Blister Pack: 60687-305-33

Lot numbers, UPCs & expiration codes

Lot, expiry: Lot 174262, exp. 03/31/2019; Lot 176469, exp. 06/30/2019; Lot 177897, exp. 08/31/2019; Lots 178318 and 178436, exp. 09/30/2019; Lot 179547 and 179656, exp. 11/30/2019

Where it was sold

Nationwide USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1820-2019
Classification
Class II
Status
Terminated
Recall initiated
Mar 1, 2019
FDA report date
Aug 21, 2019
Quantity
13,229 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
American Health Packaging

Original FDA data

Every field from FDA enforcement report D-1820-2019, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
83479
Address
2550 John Glenn Ave Ste A
Code information
Lot, expiry: Lot 174262, exp. 03/31/2019; Lot 176469, exp. 06/30/2019; Lot 177897, exp. 08/31/2019; Lots 178318 and 178436, exp. 09/30/2019; Lot 179547 and 179656, exp. 11/30/2019
Postal code
43217-1188
Report date
Aug 21, 2019
Product type
Drugs
Recall number
D-1820-2019
Classification
Class II
Recalling firm
American Health Packaging
Product quantity
13,229 cartons
Termination date
Sep 30, 2020
Reason for recall
Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Aspirin and Extended-release Dipyridamole Capsules, 25 mg/200 mg, 20 capsules per carton (5 blister cards x 4 unit doses), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-305-32; NDC Blister Pack: 60687-305-33
Distribution pattern
Nationwide USA
Recall initiation date
Mar 1, 2019
Initial firm notification
Letter
Center classification date
Aug 15, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1820-2019, published Aug 21, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls